On June 3, 2010
Amgen’s New Osteoporosis Drug: It May Not Fly Under Healthcare Reform
Biotech giant Amgen (AMGN) finally won FDA approval for an osteoporosis drug that Wall Street types predict will be the industry’s next big blockbuster — but it did so at perhaps the most precarious time in the history of the
…
0 Comments